Clarius Group, LLC - KARUNA THERAPEUTICS INC ownership

KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 248 filers reported holding KARUNA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.56 and the average weighting 0.9%.

Quarter-by-quarter ownership
Clarius Group, LLC ownership history of KARUNA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$16,777,279
-22.0%
99,2210.0%1.60%
-3.8%
Q2 2023$21,516,074
-1.0%
99,221
-17.1%
1.66%
-9.9%
Q1 2023$21,741,581
+100110.1%
119,696
+8.4%
1.85%
-5.5%
Q4 2022$21,696
-99.9%
110,413
+0.4%
1.95%
-21.0%
Q3 2022$24,735,000
+3484.8%
109,966
+1917.0%
2.47%
+3484.1%
Q2 2022$690,0005,4520.07%
Other shareholders
KARUNA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 782,008$169,578,43555.90%
Nan Fung Group Holdings Ltd 225,688$48,940,44331.28%
Sofinnova Investments, Inc. 1,381,149$299,502,16119.62%
Paradigm Biocapital Advisors LP 283,605$61,499,7444.75%
First Light Asset Management, LLC 208,746$45,266,5703.55%
Avidity Partners Management LP 442,200$95,891,0703.35%
CATALYST PRIVATE WEALTH, LLC 21,837$4,735,3532.97%
Rock Springs Capital Management LP 493,527$107,021,3302.55%
Boxer Capital, LLC 250,000$54,2132.51%
DAFNA Capital Management LLC 42,173$9,145,2152.50%
View complete list of KARUNA THERAPEUTICS INC shareholders